EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 17 March 2022

News

Pharmaceutical industry response to the war in Ukraine
05 October 2022

Supporting people affected by the war Read more

WTO proposal to waive COVID vaccine IP rights puts pandemic response at risk
16 March 2022

Since the onset of the COVID-19, our only route to address the devastating human and economic cost of the pandemic was... Read more

Blogs

Unlocking New Insights to Improve the Health of Patients
14 March 2022 - Chris Walker

With better data we can make more informed decisions and choices. Read more

Digital Health and Health Data Sharing – are patients involved in innovation?
14 March 2022 - Birgit Bauer

Moving forward together towards better digital healthcare and better patient involvement. Read more

Videos

Intellectual Property is part of the solution to get the world vaccinated against COVID-19
Intellectual property is the key driver of medical innovation. Read more

Intellectual Property - the formula to a healthy Europe
Intellectual Property has the power to bring about vital medical innovation. It can create healthy populations. It can... Read more

Events

DIA Europe 2022
29 March 2022 (Hybrid conference (virtual - Brussels))

Advancing Health Priorities Read more

11th European Conference on Rare Diseases & Orphan Products
27 June 2022 (Virtual event)

Putting rare diseases policy into action. Read more

What we are reading

Equitable access to innovative COVID-19 vaccines in Africa should focus on healthcare system...
On 23 February 2022 (Vaccines Europe)

At this moment, the number of doses produced (12.1 billion) exceeds the number of doses administered (9.2 billion). Read more

HAS-PFUE Symposium "Together for HTA in Europe"
On 07 March 2022 (HTA)

Watch the replay of the HAS-PFUE Symposium "Together for HTA in Europe" Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu